Pharmacokinetics, safety, tolerability and immunogenicity of FKB327, a new biosimilar medicine of adalimumab/Humira, in healthy subjects
暂无分享,去创建一个
A. Niewiarowski | Yasumasa Arai | S. Warrington | M. Boyce | A. Puri | H. Nomura | M. Baird | I. Dalrymple | Adeep Puri